Page last updated: 2024-08-18

pyrazolanthrone and wedelolactone

pyrazolanthrone has been researched along with wedelolactone in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1
Iida, H; Kozawa, O; Tanabe, K1

Other Studies

2 other study(ies) available for pyrazolanthrone and wedelolactone

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007
Midazolam suppresses interleukin-1β-induced interleukin-6 release from rat glial cells.
    Journal of neuroinflammation, 2011, Jun-17, Volume: 8

    Topics: Animals; Anthracenes; Cells, Cultured; Coumarins; Enzyme Inhibitors; Flavonoids; GABA Modulators; Humans; Hypnotics and Sedatives; Interleukin-1beta; Interleukin-6; Midazolam; Mitogen-Activated Protein Kinases; Neuroglia; Propofol; Rats; STAT3 Transcription Factor

2011